CVS Health Payor Solutions
Payor Solutions
Main menu
Biosimilars
About
Our Story
Who We Serve
Integrated Assets
Insights
All Insights
Care Management
Cost Management
Drug Pipeline
Government Programs & Services
Health Equity
Innovation
Public Policy
Specialty
Women's Health
Contributors
Programs & Services
Overview
Cost Management
Formulary Management
Network Strategies
Hyperinflation
Gene Therapy Solutions
Member Affordability
Specialty Management
Specialty Cost Management
Medical Benefit Solutions
Transform Oncology Care
Patient Care
Radiation Oncology
Care Management
Member Engagement
Onboarding
Benefit Plan Changes
Health Plan Client Engagement
Shortcuts
Contact Us
Resources
Videos
News
Webinars
Events
Other Sites
Client Care Access
CVS Health
CVS Caremark
CVS Specialty
CVS Pharmacy
CVS MinuteClinic
Search form
Search
Insights provides context and perspective about key pharmacy trends and issues
Format
All Formats
Briefing
Commentary
Feature
Infographic
Specialty Report
Video
White Paper
Insights Topic (field_insights_topic)
Care Management
Cost Management
Drug Pipeline
Government Programs and Services
Health Equity
Innovation
Public Policy
Specialty
Women's Health
Sort by
Most Recent
Most Popular
Insights Topic (field_insights_topic)
- Any -
Care Management
Cost Management
Drug Pipeline
Government Programs and Services
Health Equity
Innovation
Public Policy
Specialty
Women's Health
Cost Management
Q2 2023 Gene Therapy Report: Promising New Treatments on the Horizon
An update on the gene therapy pipeline
More
Briefing
Specialty
7 Stats That Show What Providers Think About Biosimilars
7 stats that show what providers think about biosimilars
More
Briefing
Cost Management
The Dynamic PBM Landscape
The changing PBM landscape holds challenges for payors
More
Commentary
Insights
offers context and perspective about key pharmacy and health care topics.
Subscribe
Cost Management
Q2 2023 Gene Therapy Report: Promising New Treatments on the Horizon
An update on the gene therapy pipeline
More
Briefing
Specialty
7 Stats That Show What Providers Think About Biosimilars
7 stats that show what providers think about biosimilars
More
Briefing
Cost Management
The Dynamic PBM Landscape
The changing PBM landscape holds challenges for payors
More
Commentary
Specialty
Advancing Our Clinical Agenda
Advancing Caremark’s clinical agenda through population health
More
Commentary
Cost Management
Connected in Care: A Proactive Approach to Managing Specialty Drugs
Lowering specialty costs through ongoing engagement with members
More
Briefing
Innovation
Understanding Environmental Threats to Member Health
Environmental threats to plan member health
More
Briefing
Women's Health
Women and Mental Health
Women and Mental Health
More
Briefing
Innovation
Advancing Our Technology Roadmap
Advancing Our Technology Roadmap
More
Briefing
Drug Pipeline
Managing New Drug Options for Obesity
...
More
Briefing
Health Equity
Understanding the Health Effects of Climate Change
Supporting Member Health in the Face of the Climate Crisis
More
Briefing
Load more